(2020). Risk Factor Control and Cardiovascular Event Risk in People With Type 2 Diabetes in Primary and Secondary Prevention Settings. Circulation. http://doi.org/10.1161/circulationaha.120.046783.
(2020). Eleven-year multimorbidity burden among 637 255 people with and without type 2 diabetes: a population-based study using primary care and linked hospitalisation data. BMJ Open. http://doi.org/10.1136/bmjopen-2019-033866.
(2020). Development and validation of the DIabetes Severity SCOre (DISSCO) in 139 626 individuals with type 2 diabetes: a retrospective cohort study. BMJ Open Diabetes Res Care. http://doi.org/10.1136/bmjdrc-2019-000962.
(2020). Age-, sex- and ethnicity-related differences in body weight, blood pressure, HbA(1c) and lipid levels at the diagnosis of type 2 diabetes relative to people without diabetes. Diabetologia. http://doi.org/10.1007/s00125-020-05169-6.
(2021). Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes: a UK-wide cohort study involving 618 161 people in primary care. BMJ Qual Saf. http://doi.org/10.1136/bmjqs-2021-013613.
(2021). Body mass index and cancer mortality in patients with incident type 2 diabetes: A population-based study of adults in England. Diabetes Obes Metab. http://doi.org/10.1111/dom.14614.
(2021). Concordance and timing in recording cancer events in primary care, hospital and mortality records for patients with and without psoriasis: A population-based cohort study. PLoS One. http://doi.org/10.1371/journal.pone.0254661.
(2021). Assessing the severity of cardiovascular disease in 213 088 patients with coronary heart disease: a retrospective cohort study. Open Heart. http://doi.org/10.1136/openhrt-2020-001498.